Welcome to our dedicated page for Raymond James SEC filings (Ticker: RJF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Raymond James Financial, Inc. (NYSE: RJF) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI‑powered summaries to help interpret complex documents. Raymond James files a range of forms with the U.S. Securities and Exchange Commission that describe its diversified financial services operations, governance and capital structure.
Investors can review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for detailed information on Raymond James’ Private Client Group, Capital Markets, Asset Management and Bank segments, as well as risk factors, management’s discussion and analysis and notes on capital and liquidity. Current reports on Form 8‑K document material events, such as the announcement of a definitive agreement to acquire Clark Capital Management Group, Inc., the redemption of the firm’s 6.375% Fixed‑to‑Floating Rate Series B Non‑Cumulative Perpetual Preferred Stock and related depositary shares, operating data releases and changes to credit facilities.
The company’s proxy statement on Schedule 14A outlines its mission, core values, corporate governance framework, board composition and executive compensation programs, as well as proposals submitted for shareholder approval. Other filings, such as Form 25 related to the delisting of the Series B preferred depositary shares, provide detail on specific securities and capital actions. Forms 3, 4 and 5, when available, disclose insider ownership and transactions in Raymond James securities.
Stock Titan’s interface surfaces these filings as they are posted to EDGAR and uses AI to highlight key points, explain technical terminology and point out items that may matter to shareholders, such as capital management decisions, segment performance disclosures and governance changes. This allows users to navigate RJF’s 10‑K, 10‑Q, 8‑K, DEF 14A and other forms more efficiently while still being able to drill into the original documents.
Raymond James Financial Chief Human Resources Officer Christopher S. Aisenbrey reported equity award activity tied to restricted stock units. On February 28, 2026, he acquired 600 shares of common stock at $0.00 per share through the exercise/conversion of 600 restricted stock units, which vest in tranches through February 28, 2027. To cover associated tax obligations, 132 common shares were disposed of at $153.08 per share, described as a payment of tax liability by delivering securities rather than an open-market sale. After these transactions, he directly owned 17,490 common shares and indirectly held 734 common shares through his Employee Stock Ownership Plan account.
Raymond James Financial director Jeffrey N. Edwards reported two bona fide gifts of common stock. On February 24, 2026, he transferred 1,503.5 shares held directly and 1,503.5 shares held indirectly through his spouse, for a total gift of 3,007 shares. After these transactions, he directly owned 9,533 shares and his spouse indirectly owned 22,008 shares.
Raymond James Financial director Raj Seshadri received an equity grant tied to board service. The filing reports an award of 1,303 Deferred Restricted Stock Units (DRSUs), which vest at the next annual shareholders meeting (but no later than March 15 of the following year). Upon vesting, each DRSU converts into one share of common stock, with additional cash in lieu of dividends, and settlement is deferred until the fifth anniversary of the vest date. Following this grant, Seshadri holds 13,782 common shares, including DRSUs.
Raymond James Financial director Raymond W. McDaniel received an equity-based compensation grant of 1,303 Deferred Restricted Stock Units (DRSUs) on common stock. These DRSUs vest at the date of the next annual shareholders meeting following the grant, but no later than March 15 of the following calendar year.
Each DRSU converts into one share of common stock at settlement, along with cash in lieu of any dividends accrued during the deferral period. According to the filing, settlement is deferred until McDaniel ends his service on the Board of Directors. Following this grant, he holds a total of 6,113 common shares and DRSUs directly.
MCGEARY RODERICK C reported acquisition or exercise transactions in this Form 4 filing.
Roderick C. McGeary, a director of Raymond James Financial Inc., received a grant of 1,303 Deferred Restricted Stock Units (DRSUs) as part of his board compensation. The DRSUs vest at the next annual shareholders meeting (no later than March 15 following grant) and then settle in common shares on a one-to-one basis on the third anniversary of vesting, per his deferral election. After this award, he directly holds a total of 24,354 shares and DRSUs of common stock.
Raymond James Financial director Anne Gates received an equity grant of 1,303 Deferred Restricted Stock Units (DRSUs) as board compensation. Each DRSU will convert into one share of common stock upon vesting, with additional cash in lieu of dividends.
The DRSUs vest at the next annual shareholders meeting following the grant, but no later than March 15 of the following calendar year. Settlement of the vested DRSUs will be deferred until the fifth anniversary of the vest date, in line with Gates’ prior election.
Raymond James Financial director Art A. Garcia acquired 1,303 Deferred Restricted Stock Units (DRSUs) as part of his Board compensation. These DRSUs convert into an equal number of common shares, plus cash in lieu of dividends, when they vest.
The units vest at the next annual shareholders meeting following the grant, but no later than March 15 of the following calendar year. Settlement of the vested DRSUs is deferred until Garcia leaves the Board, and his directly held common stock, including DRSUs, totals 6,992 shares after this grant.
Raymond James Financial director Benjamin Esty received an equity grant rather than buying shares on the market. He was awarded 1,303 Deferred Restricted Stock Units (DRSUs) as part of his Board compensation, which will convert one-for-one into common shares after vesting and later settlement. Following this grant, he holds 31,794 common shares, including DRSUs, with vesting tied to the next annual shareholders meeting and settlement deferred until he leaves the Board.
RAYMOND JAMES FINANCIAL INC director Cecily Mistarz reported equity-based compensation and related conversions on
The transactions included a grant of 1,303 shares of common stock as part of compensation for Board service and multiple RSU awards and exercises at a reported price of
Raymond James Financial director Jeffrey N. Edwards reported equity compensation activity involving restricted stock units (RSUs) and common stock. He received a grant of 1,303 RSUs, each representing a contingent right to one share of common stock plus accrued cash in lieu of dividends.
The new RSU award will vest at the date of the next annual shareholders meeting, but no later than March 15, 2027. On the same date, 1,253 previously granted RSUs vested and were exercised into 1,253 shares of common stock at a stated price of $0.00 per share.